336 related articles for article (PubMed ID: 12890688)
1. The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.
Wu-Baer F; Lagrazon K; Yuan W; Baer R
J Biol Chem; 2003 Sep; 278(37):34743-6. PubMed ID: 12890688
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase.
Nishikawa H; Ooka S; Sato K; Arima K; Okamoto J; Klevit RE; Fukuda M; Ohta T
J Biol Chem; 2004 Feb; 279(6):3916-24. PubMed ID: 14638690
[TBL] [Abstract][Full Text] [Related]
3. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.
Chen A; Kleiman FE; Manley JL; Ouchi T; Pan ZQ
J Biol Chem; 2002 Jun; 277(24):22085-92. PubMed ID: 11927591
[TBL] [Abstract][Full Text] [Related]
4. The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.
Wu-Baer F; Ludwig T; Baer R
Mol Cell Biol; 2010 Jun; 30(11):2787-98. PubMed ID: 20351172
[TBL] [Abstract][Full Text] [Related]
5. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.
Mallery DL; Vandenberg CJ; Hiom K
EMBO J; 2002 Dec; 21(24):6755-62. PubMed ID: 12485996
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.
Morris JR; Solomon E
Hum Mol Genet; 2004 Apr; 13(8):807-17. PubMed ID: 14976165
[TBL] [Abstract][Full Text] [Related]
7. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
Hashizume R; Fukuda M; Maeda I; Nishikawa H; Oyake D; Yabuki Y; Ogata H; Ohta T
J Biol Chem; 2001 May; 276(18):14537-40. PubMed ID: 11278247
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.
Xia Y; Pao GM; Chen HW; Verma IM; Hunter T
J Biol Chem; 2003 Feb; 278(7):5255-63. PubMed ID: 12431996
[TBL] [Abstract][Full Text] [Related]
9. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.
Brzovic PS; Keeffe JR; Nishikawa H; Miyamoto K; Fox D; Fukuda M; Ohta T; Klevit R
Proc Natl Acad Sci U S A; 2003 May; 100(10):5646-51. PubMed ID: 12732733
[TBL] [Abstract][Full Text] [Related]
10. Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.
Sato K; Hayami R; Wu W; Nishikawa T; Nishikawa H; Okuda Y; Ogata H; Fukuda M; Ohta T
J Biol Chem; 2004 Jul; 279(30):30919-22. PubMed ID: 15184379
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
Hayami R; Sato K; Wu W; Nishikawa T; Hiroi J; Ohtani-Kaneko R; Fukuda M; Ohta T
Cancer Res; 2005 Jan; 65(1):6-10. PubMed ID: 15665273
[TBL] [Abstract][Full Text] [Related]
12. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.
Baer R; Ludwig T
Curr Opin Genet Dev; 2002 Feb; 12(1):86-91. PubMed ID: 11790560
[TBL] [Abstract][Full Text] [Related]
13. E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages.
Christensen DE; Brzovic PS; Klevit RE
Nat Struct Mol Biol; 2007 Oct; 14(10):941-8. PubMed ID: 17873885
[TBL] [Abstract][Full Text] [Related]
14. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 DNA-binding activity is stimulated by BARD1.
Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD
Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000
[TBL] [Abstract][Full Text] [Related]
16. The BRCA1/BARD1 ubiquitin ligase and its substrates.
Witus SR; Stewart MD; Klevit RE
Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
[TBL] [Abstract][Full Text] [Related]
17. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression.
Choudhury AD; Xu H; Baer R
J Biol Chem; 2004 Aug; 279(32):33909-18. PubMed ID: 15166217
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of BRCA1-BARD1 nucleosome recognition and ubiquitylation.
Hu Q; Botuyan MV; Zhao D; Cui G; Mer E; Mer G
Nature; 2021 Aug; 596(7872):438-443. PubMed ID: 34321665
[TBL] [Abstract][Full Text] [Related]
20. Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.
McCarthy EE; Celebi JT; Baer R; Ludwig T
Mol Cell Biol; 2003 Jul; 23(14):5056-63. PubMed ID: 12832489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
